Single-Pill Combination of Telmisartan/Amlodipine in Patients With Severe Hypertension: Results From the TEAMSTA Severe HTN Study

31Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This 8-week, randomized, double-blind, controlled study compared efficacy and tolerability of telmisartan/amlodipine (T/A) single-pill combination (SPC) vs the respective monotherapies in 858 patients with severe hypertension (systolic/diastolic blood pressure [SBP/DBP] ≥180/95 mmHg). At 8weeks, T/A provided significantly greater reductions from baseline in seated trough cuff SBP/DBP (-47.5mmHg/-18.7mmHg) vs T (P

Cite

CITATION STYLE

APA

Neutel, J. M., Mancia, G., Black, H. R., Dahlöf, B., Defeo, H., Ley, L., … Zehnder, B. (2012). Single-Pill Combination of Telmisartan/Amlodipine in Patients With Severe Hypertension: Results From the TEAMSTA Severe HTN Study. Journal of Clinical Hypertension, 14(4), 206–215. https://doi.org/10.1111/j.1751-7176.2012.00595.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free